Hypermarcas (OTCMKTS:HYPMY) Posts Quarterly Earnings Results

Hypermarcas (OTCMKTS:HYPMY) announced its quarterly earnings data on Thursday. The company reported $0.13 EPS for the quarter, Zacks reports. Hypermarcas had a net margin of 12.03% and a return on equity of 6.89%. The business had revenue of $414.22 million during the quarter.

Hypermarcas Stock Performance

HYPMY traded down $0.05 on Friday, hitting $4.05. 6,284 shares of the stock traded hands, compared to its average volume of 15,007. The business has a fifty day moving average price of $4.48 and a two-hundred day moving average price of $4.42. The company has a current ratio of 1.27, a quick ratio of 0.84 and a debt-to-equity ratio of 0.61. The firm has a market capitalization of $2.56 billion, a PE ratio of 17.59 and a beta of 0.73. Hypermarcas has a 52 week low of $3.17 and a 52 week high of $5.50.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.